Claris Lifesciences (CLL) IPO – Upcoming IPO Claris Lifesciences Limited (CLL)

Table of Contents

Claris Lifesciences Limited (CLL) IPO Information:

– Issue Open: 24-Nov-10
– Issue Close: 3-Dec-10 (Revised IPO Closing Date)
– Issue Size: Rs. 300 Crore
– Face Value: Rs. 10 / Equity Share
– Issue Price: Rs. 228 – Rs. 235 Per Equity Share (Revised IPO Price Band)
– Minimum Quantity: 22 Shares (Rs. 5170 with 1 Lot)
– Maximum Quantity: 682 Shares (Rs. 160270 with 31 Lot) (Max 200000)
– Listing At: BSE

Maximum Subscription Amount for Retail Investor: Rs. 200000

About Company:
Claris Lifesciences is one of the largest sterile injectables pharmaceutical companies in India with a market presence in 76 countries worldwide. We primarily manufacture and market products across multiple markets, and therapeutic segments. A significant majority of these products are generic drugs that are capable of being directly injected into the human body and are predominantly used in the treatment of critical illnesses.

Contact Information:
Registered Office : Claris Corporate Headquarters, Near Parimal Railway Crossing, Ellisbridge, Ahmedabad – 380 006
Phone: +91 79 26563331
Fax: +91 79 26565879
Email: [email protected]

Book Running Lead Manager(s)
1. Edelweiss Capital Limited
2. Enam Securities Private Limited
3. ICICI Securities Limited
4. JM Financial Consultants Private Limited

Registrar of Claris Lifesciences Limited (CLL)
Link Intime India Private Ltd
Phone: +91-22-25963838
Fax: +91-22-25946969
Email: [email protected]

More Information: 
Claris Lifesciences Limited (CLL) Grey Market Premium & Kostak Rates: Click Here
Claris Lifesciences Limited (CLL) Listing Date: Click Here

Share the Post:

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.